$AZN Company News Drug makers face another $65 billion

New Post Public Reply Private Reply Replies (0) Message Board

Dec 19, 2014 at 12:53 PM

$AZN Company News

Drug makers face another $65 billion patent cliff 12:42 p.m. Dec. 10, 2014 - Russ Britt
Eli Lilly, AstraZeneca launch patient trial for Alzheimer's treatment 7:19 a.m. Dec. 1, 2014 - Tomi Kilgore
AstraZeneca advances in London; pound rises as inflation ticks up 11:59 a.m. Nov. 18, 2014 - Carla Mozee
AstraZeneca forecasts revenue of $45 bln by 2023 2:43 a.m. Nov. 18, 2014 - MarketWatch.com
FDA revokes Ranbaxy’s right to generic versions of Nexium, Valcyte 11:05 a.m. Nov. 6, 2014 - Sean McLain
AstraZeneca lifts 2014 guidance as profit slides 2:33 a.m. Nov. 6, 2014 - MarketWatch.com
Pfizer sales fall less than expected 6:34 a.m. Oct. 28, 2014 - MarketWatch.com
Eli Lilly's sales hit again by patent expirations 5:59 a.m. Oct. 23, 2014 - MarketWatch.com
3 stocks Ken Fisher likes 10:09 a.m. Oct. 21, 2014 - Insider Monkey
FTSE 100 teetering on edge of correction; Shire sinks in London 12:13 p.m. Oct. 15, 2014 - Carla Mozee
Is the AbbVie-Shire deal dead? Stock market thinks so 6:05 a.m. Oct. 15, 2014 - Sara Sjolin
FTSE 100 falls amid broader European selloff 11:02 a.m. Oct. 7, 2014 - Sara Sjolin
TNT Express slumps; Rio Tinto climbs: Europe’s stock movers 11:12 a.m. Sept. 24, 2014 - Sara Sjolin
Rio Tinto, Vodafone lift FTSE 100 for first day in three 11:11 a.m. Sept. 24, 2014 - Sara Sjolin
Pfizer held takeover talks with Actavis 12:33 a.m. Sept. 24, 2014 - Jonathan D. Rockoff
CF Industries rises on merger talks; AstraZeneca, AbbVie fall 2:21 p.m. Sept. 23, 2014 - Sue Chang
Burger King, AbbVie among stocks hit by new tax inversion rules 1:41 p.m. Sept. 23, 2014 - Ben Eisen
Eli Lilly agrees to co-develop AstraZeneca's Alzheimer's treatment 6:17 a.m. Sept. 16, 2014 - Tomi Kilgore
Lilly to pay AstraZeneca up to $500 mln as part of Alzheimer's treatment agreement 6:04 a.m. Sept. 16, 2014 - Tomi Kilgore
Eli Lilly, AstraZeneca agree to co-develop Alzheimer's treatment 6:03 a.m. Sept. 16, 2014 - Tomi Kilgore

Update: AstraZeneca Wins EU Approval For Lynparza 1:13 a.m. Today - Seeking Alpha
Tax Inversions Wrap Up 3:01 p.m. Dec. 18, 2014 - Seeking Alpha
AstraZeneca cancer drug cleared in Europe 7:22 a.m. Dec. 18, 2014 - Seeking Alpha
Is A Dividend Cut The End Of The World? Analysis Of Dividend-Cutting Companies, Part I 6:04 p.m. Dec. 17, 2014 - Seeking Alpha
Meet 5 Big Tech Stocks Expected To See Profits Surge 8:03 p.m. Dec. 16, 2014 - Investors Business Daily
Theravance Biopharma Pipeline Valuation 7:43 a.m. Dec. 16, 2014 - Seeking Alpha
Money flow surges in AstraZeneca 10:38 a.m. Dec. 11, 2014 - Seeking Alpha
Nektar/AstraZeneca's Moventig Gets EU Approval for OIC - Analyst Blog 6:50 p.m. Dec. 10, 2014 - Zacks.com
Merck's Keytruda Might Treat Virulent Breast Cancer 10:04 a.m. Dec. 10, 2014 - Investors Business Daily
AstraZeneca (AZN) Moving On Heavy Volume In The Pre-Market Hours 9:24 a.m. Dec. 10, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – NBIX TECH AZN ISIS 7:30 a.m. Dec. 10, 2014 - InvestorPlace.com
Dynavax & AstraZeneca Alter Agreement for Asthma Product - Analyst Blog 6:20 p.m. Dec. 9, 2014 - Zacks.com
Update: AstraZeneca Wins EU Approval For Moventig 2:46 p.m. Dec. 9, 2014 - Seeking Alpha
Take the Risk for Reward With Pfizer Options 9:00 a.m. Dec. 9, 2014 - InvestorPlace.com
Moventig cleared in Europe for OIC 7:14 a.m. Dec. 9, 2014 - Seeking Alpha
Actavis' Antibiotic Backed for FDA Approval, Response in Q1 - Analyst Blog 6:30 p.m. Dec. 8, 2014 - Zacks.com
Assessing The Magnitude Of Pfizer's Coming Dividend Increase 3:11 p.m. Dec. 8, 2014 - Seeking Alpha
Seattle Genetics down on ASH presentations 12:37 p.m. Dec. 8, 2014 - Seeking Alpha
Dynavax to initiate asthma trial 10:55 a.m. Dec. 8, 2014 - Seeking Alpha
Time To Focus On What's Good 4:59 p.m. Dec. 7, 2014 - Seeking Alpha

Amgen And AstraZeneca To Present Results From Phase 3 AMAGINE-1™ Study Evaluating Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4:01 p.m. Dec. 11, 2014 - PR Newswire - PRF
Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4:01 p.m. Nov. 25, 2014 - PR Newswire - PRF
AstraZeneca Announces Plans to Expand its Frederick, Maryland Biologics Manufacturing Center 11:08 a.m. Nov. 21, 2014 - BusinessWire - BZX
Global Oncology Market to hit $109 billion - Spotlight on Drug Life Cycle Management, M&A and Pipeline Strategies 11:37 a.m. Nov. 19, 2014 - PR Newswire - PRF
Cancer Diagnostics Market (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 1:33 p.m. Nov. 18, 2014 - PR Newswire - PRF
AstraZeneca Presents Data from Phase III Studies of Lesinurad in Combination with Allopurinol in Gout Patients at American College of Rheumatology 2014 Annual Meeting 9:00 a.m. Nov. 16, 2014 - BusinessWire - BZX
Cleveland Biolabs; A Diverse Play on Both Biodefense and Cancer 10:51 a.m. Nov. 13, 2014 - ACCESSWIRE
Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4:01 p.m. Nov. 11, 2014 - PR Newswire - PRF
Pharma Equities Technical Data - Salix Pharma, AstraZeneca, Novartis, Impax Laboratories, and Novo Nordisk 9:05 a.m. Nov. 11, 2014 - PR Newswire - PRF
U.S. FDA Approves Once-Daily XIGDUO™ XR Tablets for Adults with Type 2 Diabetes 6:05 a.m. Oct. 30, 2014 - BusinessWire - BZX
Global Pediatric Drugs and Vaccines Market 4:08 p.m. Oct. 23, 2014 - PR Newswire - PRF
Ardelyx's Tenapanor Selected for Oral and Poster Presentations at the American Society of Nephrology's Kidney Week 2014 9:30 a.m. Oct. 23, 2014 - PR Newswire - PRF
AstraZeneca Launches Fit2Me™, a Free Customized Diet and Lifestyle Support Program for People with Type 2 Diabetes 6:31 a.m. Oct. 15, 2014 - BusinessWire - BZX
Branding Campaign, Asset Sale, Executive Promotion, Clinical Data Presentation, and Drug Approval Update - Research Reports on Synchrony Financial, Avalonbay, Aflac, Teva and AstraZeneca 7:35 a.m. Oct. 7, 2014 - PR Newswire - PRF
Technical Updates on Health Care Sector Stocks - AstraZeneca, Novartis, Salix Pharma, Inovio Pharma, and CTI BioPharma 8:15 a.m. Oct. 6, 2014 - PR Newswire - PRF
Actor James Van Der Beek and AstraZeneca Join Forces to Educate Families about Influenza 10:34 a.m. Sept. 15, 2014 - PR Newswire - PRF
Actor James Van Der Beek and AstraZeneca Join Forces to Educate Families about Influenza 7:09 a.m. Sept. 15, 2014 - PR Newswire - PRF
Publishing of Clinical Study Data, Employee Recognition, Market Activity, Investment in Infrastructure - Research Reports on AstraZeneca, Northrop Grumman, Corning, PPL Corp. and Edison 8:10 a.m. Sept. 11, 2014 - PR Newswire - PRF
Trialbee Helps AstraZeneca Reduce the Time Required for Recruitment of Patients to Clinical Trials 6:32 a.m. Sept. 10, 2014 - BusinessWire - BZX
Favourable Rulings, Upcoming Conferences, Clinical Study Results, Drug Availability, and Tender Offers - Research Reports on United Therapeutics, Illumina, AstraZeneca, Eli Lilly and Abbott 8:20 a.m. Sept. 3, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HiBy Unveils Cyberpunk 2077 Gaming Audio Line

HiBy Hits the Gaming Scene with Cyberpunk Flair It's a wild world when audio tech and gaming collide outside of the usual suspects. HiBy's latest move is a bold pivot into the gaming universe, launching an audacious collaboration with, of all things, the cybernetic chaos of Cyberpunk 2077. You can almost feel the underlying scrappiness of Night City embedded into a couple...

Hyundai Teases 2027 TUCSON: Global Reveal Imminent

Hyundai Sets the Stage for the 2027 TUCSON Hyundai’s ready to roll out its shiny new set of wheels, the 2027 TUCSON, and boy, they sure know how to make an entrance. Mark your calendars for October 1—it's happening right in the Big Apple, none other than Long Island City. Expect the spotlight to hit at precisely 5:15 p.m. ET, and don't worry if you can't snag a...

Gray's Rise in ENR Rankings Highlights Sector Dominance

Gray's Outstanding Reputation in the Construction Arena Nothing says “we're on top of our game” like snatching top slots in industry rankings, and that's precisely what Gray, the construction and engineering heavyweight, has managed to do. This firm recently secured impressive spots across ten different categories in the prestigious Engineering News-Record (ENR) Top...

BLM's Wild Horse Strategy: Fertility Control's Time to Shine

Wild Horse Management Gets a Shot in the Arm Amigo, when the federal government throws $30 million dollars at a problem, you'd hope they're not just throwing us a bone. The Bureau of Land Management (BLM) now has this hefty sum courtesy of the U.S. Department of Agriculture, intended to expand wild horse fertility control across the sprawling landscapes they roam. This...

Alito's Recusal: Supreme Court Climate Case Shaker

Justice Alito Bows Out from A High-Stakes Climate Battle September 28, 2026, marked a notable turn in the legal landscape. Supreme Court Justice Samuel Alito chose to step away from a case that's got every investor, lawyer, and policy wonk on the edge of their seats—Suncor v. Boulder. This isn't about just any old courtroom squabble; it's a landmark climate case poised...

Janitorial Wages Soar 26.7% Amid High Annual Openings

Janitorial Sector Faces Wage Surge and Employment Shifts Look, if you thought the world of janitorial work was all brooms and mops without a paycheck edge, think again. From 2020 to 2025, wages for janitors and building cleaners didn't just tip-toe up the ladder—they practically sprinted, climbing 26.7%. BLS data laid this one out, with hourly pay shooting from $13.98...

LifeLabs' AI Program: A Manager's New Toolbox

Management In the Age of AI: New Frontiers Gone are the days when a simple software update meant staying competitive. We're in a new era, folks—one where AI isn't just a handy tool—it's reshaping entire industries. But here's the kicker: all the fancy tech in the world won't do squat without savvy managers who know how to drive adoption. Yup, that's the naked truth,...

Understanding Criminal Threat Charges in Kansas

The Intricacies of Criminal Threat Cases in Kansas Let's cut straight to it: not all heated exchanges land you in court, but words can slap you with a criminal threat charge in Kansas if mishandled. A simple spat can turn legal nightmare, making it crucial to grasp the nuances of these cases. What sets them apart from other charges is the absence of physical...

Beasley and Vegas Golden Knights Partner for Broadcast

Strategic Moves on the Airwaves The Vegas Golden Knights are skating into a new era of broadcasting. Teaming up with Beasley Media Group, they've inked a multiyear deal that makes the media outfit their official audio partner. Dropping the puck on this relationship means folks in Southern Nevada can catch the action on Beasley's English and Spanish stations. It's a hefty...

Multiply's AI Agent Tackles $126K Google Ads Waste

AI Steps In Where Marketers Hit a Wall Picture this: marketers drowning in search terms flying at them faster than they can blink. Multiply's new AI-powered Ad Spend Recovery Agent steps in, claiming to save an eye-watering $126,000 per year by cutting Google Ads waste. Talk about having a hawk-eyed auditor sifting through your accounts. Shaking Up Traditional Automation...